SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (22198)6/15/1998 2:20:00 PM
From: Harold Engstrom  Read Replies (1) of 32384
 
The return that Ligand shareholders have seen is very poor. How do you assess the actual value of the pipeline?

Just as importantly, is it possible to assess Ligand's infrastructure and its ability to deliver: process development, manufacturing, ability to conduct effective clinicals, marketing, sales, distribution, etc.... ? Is Ligand capable of actually bringing significant products to market in a timely way?

Also, is it possible to trust management that has so little regard for return to shareholders. Ligand management should husband its capital rather than lavish it on themselves and spend it wastefully on programs. What commitment has Ligand management made to its shareholders that will ensure that it succeeds?

Can Ligand make it?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext